Back to Results
First PageMeta Content
Lysosomal storage diseases / Glycogen storage disease type II / Hepatology / Alglucosidase alfa / Medicine / Health / Rare diseases


Stakeholder meeting outcome statement Alglucosidase alfa (Myozyme®) for the treatment of Late-Onset Pompe Disease A stakeholder meeting was held on 9 October 2014 to discuss the development of eligibility guidelines for
Add to Reading List

Document Date: 2015-03-12 23:53:04


Open Document

File Size: 218,41 KB

Share Result on Facebook
UPDATE